Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 4, 2018New England Journal of MedicineOpen Access

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMerrill D. BensonSouthwestern Medical CenterMWMárcia Waddington‐CruzUniversidade Federal do Rio de JaneiroJBJohn L. BerkBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Benson et al. (2018) studied this question.

synapsesocial.com/papers/69d6893b2c8f994bcf1f2eb2https://doi.org/10.1056/nejmoa1716793
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy2003 · 72 citations
  2. 2The Development and Validation of the Norfolk QOL-DN, a New Measure of Patients' Perception of the Effects of Diabetes and Diabetic Neuropathy2005 · 240 citations
  3. 3Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers2016 · 118 citations
  4. 4Repurposing Diflunisal for Familial Amyloid Polyneuropathy2013 · 713 citations
  5. 5Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial2017 · 56 citations